HORSHAM, Pa., Jan. 28, 2016 -- Symphony Health Solutions, a provider of high-value market research, analytics and technology solutions for life science manufacturers, researchers, payers and providers, today announced that multiple members of the company’s consulting practice have been selected as presenters for the 2016 Pharmaceutical Management Science Association (PMSA) Annual Conference in Las Vegas this April. The PMSA Annual Conference is a forum for life science industry experts to network, exchange best practices, and learn about emerging trends in analytics for the pharmaceutical industry.
Symphony’s Ewa Kleczyk, PhD, Executive Director of Consulting and Services, and Derek Evans, Sr. Vice President and Commercial Effectiveness Practice Head, will present “Leveraging Secondary Physician and Patient Level Data to Predict Physician Attitudinal Segment Assignments”. Their presentation will provide an overview of Symphony’s proprietary Hybrid Segmentation solution which allows the projection of physician segments to a larger physician list by leveraging the attitudinal information, robustness of secondary data, and proprietary physician level prescribing propensities. Through use of a case study in the Oncology area, the presentation will review methodology steps needed to ensure that the “Hybrid” approach yields high accuracy prediction and consistency in assigning physicians into intended segments.
Christopher Casten, Managed Markets Principal at Symphony, will present “Do You Really Need to Contract with a Payer?” Payer contracting can be the most significant spend that manufacturers believe will drive brand access. But the lack of insight into the patient’s ability to ultimately receive the brand, even without a manufacturer/payer contract, can have significant financial impact on a brand’s revenue. This presentation will review an actual, historical study done in conjunction with a major, US biologic manufacturer to show the impact of benefit design and payer contracting on patients’ ability to fill their prescriptions.
In addition to the presentations, Symphony will exhibit several posters in the conference’s Poster Sessions:
- Alternative Methodologies of Measuring Medication Usage Amongst Chronically Ill patients with Idiosyncratic Treatment Plan
- Measuring Media Exposure with Health Behavior and Patient Pathing Metrics
- Launching an Oncology Brand – Get it Right Using Big Data
Poster authors and representatives from Symphony Health Solutions will be present throughout the conference to share insights into how data and analytics from Symphony’s IDV® (Integrated Dataverse) can answer key questions and facilitate critical commercial processes within sales, marketing, and managed markets.
Symphony Health Solutions is proud to continue a long-standing relationship with PMSA. During the 2015 Annual Conference, Michael Venters, Product Management Director at Symphony, delivered a presentation on Prescription Buy-Down Program Effectiveness. PMSA and Symphony also partnered throughout the summer of 2015 to offer a four-installment Data Training Webinar Series presented by Symphony Health’s Laura Jirele.
PMSA, focused this year on Game-Changing Analytics: The Odds Are in Your Favor, will be held April 17-20, 2016 at Planet Hollywood Hotel in Las Vegas, Nevada. For more information or to register for the PMSA 2016 Annual Conference, visit the website.
For more information about Symphony Health Solutions, visit www.symphonyhealth.com.
About Symphony Health Solutions
Symphony Health Solutions is a leading provider of high-value data, analytics, technology solutions and actionable insights for healthcare and life sciences manufacturers, payers and providers. The company helps clients drive revenue growth and commercial effectiveness, while adapting to the transformation of the healthcare ecosystem, by integrating a broad set of patient, prescriber, payer and clinical data together with primary and secondary health research, analytics and consulting. Symphony delivers a comprehensive perspective on the real dynamics that drive business in the healthcare and life sciences markets. For more information, visit www.symphonyhealth.com.
For media information, please contact: Heather Varela, Symphony Health Solutions [email protected] +1 602.463.7838


J.P. Morgan Sees Potential Vestas Guidance Upgrade Amid Strong Wind Energy Demand
NTSB Investigates Boston Logan Airport Near-Miss Between Delta and American Airlines Jets
Alphabet Stock Slides as AI Talent Exodus and SpaceX Losses Shake Investor Confidence
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates
Frank Stronach Found Guilty of Sexual Assault and Indecent Assault in Ontario Court
Ukrainian Drone Makers Target Japan and Asia Defense Market
Trump Says Anthropic No Longer Seen as National Security Threat
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge
Hyundai to Acquire SoftBank’s Remaining Boston Dynamics Stake for $325 Million
Qantas Unveils Wellness-Focused Nonstop Sydney-London Flights to Reduce Jet Lag
DOJ Opens Investigation Into NYC Coffee Shop Over Anti-Goldman Social Media Post
Google’s Open-Source AI Data Center Cooling Design Raises Commoditization Concerns
Qualcomm Nears $4 Billion Acquisition of AI Chip Startup Modular
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 



